Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach

Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach

Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that block immune checkpoints and therefore activate immune cells, allowing them to recognize and attack cancer cells. ICIs have revolutionized oncology practice, but their use has been complicated by immune-related adverse events (irAEs)...

Full description

Bibliographic Details
Main Authors: Gillian Murtagh, Christopher deFilippi, Qiong Zhao, Ana Barac
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
cardiotoxicity
biomarkers
myocarditis
immune checkpoint inhibitors
immuno-oncology
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1350585/full

Similar Items

Similar Items